JP2002513019A - パロキセチン・アスコルビン酸塩 - Google Patents
パロキセチン・アスコルビン酸塩Info
- Publication number
- JP2002513019A JP2002513019A JP2000545858A JP2000545858A JP2002513019A JP 2002513019 A JP2002513019 A JP 2002513019A JP 2000545858 A JP2000545858 A JP 2000545858A JP 2000545858 A JP2000545858 A JP 2000545858A JP 2002513019 A JP2002513019 A JP 2002513019A
- Authority
- JP
- Japan
- Prior art keywords
- paroxetine
- present
- ascorbate
- solution
- paroxetine ascorbate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4525—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Psychology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9808896.6A GB9808896D0 (en) | 1998-04-25 | 1998-04-25 | Novel compound |
GB9808896.6 | 1998-04-25 | ||
PCT/GB1999/001244 WO1999055698A1 (en) | 1998-04-25 | 1999-04-23 | Paroxetine ascorbate |
Publications (1)
Publication Number | Publication Date |
---|---|
JP2002513019A true JP2002513019A (ja) | 2002-05-08 |
Family
ID=10831008
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2000545858A Pending JP2002513019A (ja) | 1998-04-25 | 1999-04-23 | パロキセチン・アスコルビン酸塩 |
Country Status (20)
Country | Link |
---|---|
EP (1) | EP1089995A1 (zh) |
JP (1) | JP2002513019A (zh) |
KR (1) | KR20010042977A (zh) |
CN (1) | CN1297448A (zh) |
AP (1) | AP2000001963A0 (zh) |
AU (1) | AU3618499A (zh) |
BG (1) | BG104940A (zh) |
BR (1) | BR9909868A (zh) |
CA (1) | CA2330055A1 (zh) |
EA (1) | EA200001104A1 (zh) |
GB (1) | GB9808896D0 (zh) |
HU (1) | HUP0102116A3 (zh) |
ID (2) | ID26654A (zh) |
IL (1) | IL139081A0 (zh) |
NO (1) | NO20005352L (zh) |
PL (1) | PL343677A1 (zh) |
SK (1) | SK15912000A3 (zh) |
TR (1) | TR200003084T2 (zh) |
WO (1) | WO1999055698A1 (zh) |
ZA (1) | ZA200005912B (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2005520803A (ja) * | 2002-01-09 | 2005-07-14 | エミスフェアー・テクノロジーズ・インク | 4−[(4−クロロ−2−ヒドロキシベンゾイル)アミノ]ブタン酸ナトリウムの多形体 |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0003232D0 (en) * | 2000-02-11 | 2000-04-05 | Smithkline Beecham Plc | Novel composition |
IL159280A0 (en) * | 2001-06-14 | 2004-06-01 | Teva Pharma | A process for preparing paroxetine hcl which limits formation of pink colored compounds |
CN118267895A (zh) * | 2018-10-30 | 2024-07-02 | 中国科学院化学研究所 | 一种制备药物或药物中间体无定型物的方法 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1422263A (en) * | 1973-01-30 | 1976-01-21 | Ferrosan As | 4-phenyl-piperidine compounds |
ES2058061T3 (es) * | 1985-10-25 | 1994-11-01 | Beecham Group Plc | Derivado de piperidina, su preparacion y su uso como medicamento. |
US5276042A (en) * | 1993-04-16 | 1994-01-04 | Crenshaw Roger T | Treatment of premature ejaculation |
ES2117557B1 (es) * | 1996-02-29 | 1999-07-01 | Ferrer Int | Nuevo procedimiento de obtencion de (-)-trans -n-p-fluorobenzoilmetil-4-(p-fluorofenil)-3- ((3,4-(metilendioxi)fenoxi ) metil)-piperidina. |
-
1998
- 1998-04-25 GB GBGB9808896.6A patent/GB9808896D0/en not_active Ceased
-
1999
- 1999-04-23 JP JP2000545858A patent/JP2002513019A/ja active Pending
- 1999-04-23 ID IDW20002169A patent/ID26654A/id unknown
- 1999-04-23 HU HU0102116A patent/HUP0102116A3/hu unknown
- 1999-04-23 CA CA002330055A patent/CA2330055A1/en not_active Abandoned
- 1999-04-23 EP EP99918151A patent/EP1089995A1/en not_active Withdrawn
- 1999-04-23 CN CN99805160A patent/CN1297448A/zh active Pending
- 1999-04-23 AU AU36184/99A patent/AU3618499A/en not_active Abandoned
- 1999-04-23 TR TR2000/03084T patent/TR200003084T2/xx unknown
- 1999-04-23 BR BR9909868-7A patent/BR9909868A/pt not_active Application Discontinuation
- 1999-04-23 KR KR1020007011809A patent/KR20010042977A/ko not_active Application Discontinuation
- 1999-04-23 AP APAP/P/2000/001963A patent/AP2000001963A0/en unknown
- 1999-04-23 ID IDW20002168A patent/ID26083A/id unknown
- 1999-04-23 PL PL99343677A patent/PL343677A1/xx not_active Application Discontinuation
- 1999-04-23 SK SK1591-2000A patent/SK15912000A3/sk unknown
- 1999-04-23 EA EA200001104A patent/EA200001104A1/ru unknown
- 1999-04-23 WO PCT/GB1999/001244 patent/WO1999055698A1/en not_active Application Discontinuation
- 1999-04-23 IL IL13908199A patent/IL139081A0/xx unknown
-
2000
- 2000-10-23 ZA ZA200005912A patent/ZA200005912B/en unknown
- 2000-10-24 NO NO20005352A patent/NO20005352L/no not_active Application Discontinuation
- 2000-11-13 BG BG104940A patent/BG104940A/bg unknown
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2005520803A (ja) * | 2002-01-09 | 2005-07-14 | エミスフェアー・テクノロジーズ・インク | 4−[(4−クロロ−2−ヒドロキシベンゾイル)アミノ]ブタン酸ナトリウムの多形体 |
US7893297B2 (en) | 2002-01-09 | 2011-02-22 | Emisphere Technologies, Inc. | Amorphous sodium 4-[4-chloro-2-hydroxybenzoyl)amino]butanoate |
Also Published As
Publication number | Publication date |
---|---|
GB9808896D0 (en) | 1998-06-24 |
TR200003084T2 (tr) | 2001-02-21 |
AP2000001963A0 (en) | 2000-12-31 |
ID26083A (id) | 2000-11-23 |
EA200001104A1 (ru) | 2001-04-23 |
EP1089995A1 (en) | 2001-04-11 |
AU3618499A (en) | 1999-11-16 |
HUP0102116A3 (en) | 2002-12-28 |
HUP0102116A2 (hu) | 2002-05-29 |
NO20005352D0 (no) | 2000-10-24 |
PL343677A1 (en) | 2001-08-27 |
IL139081A0 (en) | 2001-11-25 |
CA2330055A1 (en) | 1999-11-04 |
WO1999055698A1 (en) | 1999-11-04 |
BG104940A (bg) | 2001-09-28 |
ZA200005912B (en) | 2001-12-19 |
NO20005352L (no) | 2000-10-24 |
ID26654A (id) | 2001-01-25 |
KR20010042977A (ko) | 2001-05-25 |
CN1297448A (zh) | 2001-05-30 |
SK15912000A3 (sk) | 2001-04-09 |
BR9909868A (pt) | 2000-12-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE60018040T2 (de) | Polymorphische kristalline formen von celecoxib | |
WO2003013529A1 (en) | Paroxetine glycyrrhizinate | |
KR20060135866A (ko) | 바제독시펜 아세테이트의 결정질 다형체 | |
JP2007532548A (ja) | バゼドキシフェンアセテートの結晶質多形体 | |
EP1014987B1 (en) | Oral compositions of levosimendan | |
JP3518601B2 (ja) | エバスタイムまたはその類似体に基づく医薬組成物 | |
EP1844017A1 (en) | An amorphous and three crystalline forms of rimonabant hydrochloride | |
JP2002505254A (ja) | パロキセチン塩 | |
JP2002513019A (ja) | パロキセチン・アスコルビン酸塩 | |
JP2003527424A (ja) | オキサゾリジノン錠剤製剤 | |
JP2002511466A (ja) | マレイン酸パロキセチン | |
JP2002513020A (ja) | Cns疾患治療のための10−ショウノウスルホン酸パロキセチン | |
MXPA00010439A (en) | Paroxetine ascorbate | |
MXPA00010435A (en) | Paroxetine 10-camphorsulfonate for treatment of cns disorders | |
JP2951410B2 (ja) | 結晶(―)―3r,4r―トランス―7―メトキシ―2,2―ジメチル―3―フェニル―4―{4―〔2―(ピロリジン―1―イル)エトキシ〕フェニル}クロマン・酸性フマル酸塩 | |
CZ20003942A3 (cs) | Askorbat paroxetinu | |
JP2002531453A (ja) | パロキセチン塩酸塩アセトン溶媒和物の製法 | |
WO2001014369A2 (en) | Process for the preparation of paroxetin.hcl | |
CZ20003722A3 (cs) | Maleat paroxetinu | |
AU2528899A (en) | Salts of paroxetine | |
MXPA00007719A (en) | Salts of paroxetine | |
CZ20003941A3 (cs) | 10-KafrsuIfonat paroxetinu pro léčbu poruch centrálního nervového systému | |
MXPA00009884A (en) | Paroxetine maleate | |
JP2002516611A (ja) | 結晶性(−)−3r,4r−トランス−7−メトキシ−2,2−ジメチル−3−フェニル−4−{4−〔2−(ピロリジン−1−イル)エトキシ〕フェニル}クロマン水素マレエート | |
MXPA06011717A (en) | Crystalline polymorph of bazedoxifene acetate |